Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Biogen Idec Company Profile (NASDAQ:BIIB)

Consensus Ratings for Biogen Idec (NASDAQ:BIIB) (?)
Ratings Breakdown: 5 Hold Rating(s), 15 Buy Rating(s)
Consensus Rating:Buy (Score: 2.75)
Consensus Price Target: $438.64 (12.68% upside)

Current Analysts' Coverage Summary for Biogen Idec (NASDAQ:BIIB)
Show:
DateFirmActionRatingPrice TargetDetailsShare
4/27/2015ArgusBoost Price TargetBuy$440.00 -> $450.00ViewTweet This Rating  Share This Rating on StockTwits
4/27/2015NomuraBoost Price TargetNeutral$401.00 -> $442.00ViewTweet This Rating  Share This Rating on StockTwits
4/27/2015Citigroup Inc.Lower Price TargetBuy$512.00 -> $497.00ViewTweet This Rating  Share This Rating on StockTwits
4/27/2015OppenheimerInitiated CoverageMarket PerformViewTweet This Rating  Share This Rating on StockTwits
4/27/2015Vetr Inc.UpgradeSell -> Hold$423.58ViewTweet This Rating  Share This Rating on StockTwits
4/26/2015JPMorgan Chase & Co.Reiterated RatingBuyViewTweet This Rating  Share This Rating on StockTwits
4/24/2015Morgan StanleyReiterated RatingBuyViewTweet This Rating  Share This Rating on StockTwits
4/24/2015Piper JaffraySet Price TargetBuy$485.00ViewTweet This Rating  Share This Rating on StockTwits
4/24/2015BMO Capital MarketsSet Price TargetBuy$511.00ViewTweet This Rating  Share This Rating on StockTwits
4/9/2015Deutsche BankReiterated RatingBuyViewTweet This Rating  Share This Rating on StockTwits
4/1/2015BarclaysReiterated RatingOverweight$500.00ViewTweet This Rating  Share This Rating on StockTwits
3/23/2015Stifel NicolausDowngradeBuy -> Hold$451.00ViewTweet This Rating  Share This Rating on StockTwits
3/18/2015RBC CapitalReiterated RatingBuyViewTweet This Rating  Share This Rating on StockTwits
1/29/2015Credit Suisse Group AGReiterated RatingOutperform$400.00ViewTweet This Rating  Share This Rating on StockTwits
12/3/2014S&P Equity ResearchReiterated RatingBuyViewTweet This Rating  Share This Rating on StockTwits
11/24/2014Leerink SwannInitiated CoverageOutperform$370.00ViewTweet This Rating  Share This Rating on StockTwits
11/6/2014ZacksUpgradeNeutral -> Outperform$383.00ViewTweet This Rating  Share This Rating on StockTwits
10/22/2014Robert W. BairdUpgradeNeutral -> Outperform$382.00ViewTweet This Rating  Share This Rating on StockTwits
10/1/2014Bank of AmericaInitiated CoverageNeutral$371.00ViewTweet This Rating  Share This Rating on StockTwits
7/24/2014Jefferies GroupReiterated RatingBuy$380.00 -> $410.00ViewTweet This Rating  Share This Rating on StockTwits
3/3/2014TheStreetReiterated RatingPositive -> BuyViewTweet This Rating  Share This Rating on StockTwits
1/30/2014Brean CapitalBoost Price TargetBuy$293.00 -> $377.00ViewTweet This Rating  Share This Rating on StockTwits
1/27/2014Canaccord GenuityBoost Price TargetBuy$291.00 -> $355.00ViewTweet This Rating  Share This Rating on StockTwits
10/30/2013FBR & Co.UpgradeUnderperform -> Market PerformViewTweet This Rating  Share This Rating on StockTwits
10/29/2013GuggenheimBoost Price TargetNeutral$228.00 -> $247.00ViewTweet This Rating  Share This Rating on StockTwits
10/22/2013Wells Fargo & Co.Reiterated RatingPositiveViewTweet This Rating  Share This Rating on StockTwits
9/18/2013Goldman SachsBoost Price Target$220.00 -> $240.00ViewTweet This Rating  Share This Rating on StockTwits
7/10/2013Sanford C. BernsteinReiterated RatingMarket Perform$231.00ViewTweet This Rating  Share This Rating on StockTwits
5/29/2013Cowen and CompanyReiterated RatingOutperformViewTweet This Rating  Share This Rating on StockTwits
5/20/2013Evercore ISIReiterated RatingBuyViewTweet This Rating  Share This Rating on StockTwits
5/9/2013MKM PartnersBoost Price TargetNeutral$208.00 -> $215.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 4/28/2013 forward)